$32.28
0.91% yesterday
Nasdaq, May 20, 09:48 pm CET
ISIN
US74838J1016
Symbol
QDEL

Quidel Corporation Stock price

$32.38
+7.82 31.84% 1M
-5.10 13.61% 6M
-12.17 27.32% YTD
-10.01 23.61% 1Y
-67.53 67.59% 3Y
-154.41 82.67% 5Y
+9.40 40.91% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.19 0.58%
ISIN
US74838J1016
Symbol
QDEL
Sector

Key metrics

Market capitalization $2.19b
Enterprise Value $4.76b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.72
P/S ratio (TTM) P/S ratio 0.79
P/B ratio (TTM) P/B ratio 0.73
Revenue growth (TTM) Revenue growth -3.18%
Revenue (TTM) Revenue $2.77b
EBIT (operating result TTM) EBIT $88.30m
Free Cash Flow (TTM) Free Cash Flow $-35.90m
Cash position $127.10m
EPS (TTM) EPS $-4.96
P/E forward negative
P/S forward 0.81
EV/Sales forward 1.75
Short interest 10.60%
Show more

Is Quidel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Quidel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Quidel Corporation forecast:

7x Buy
70%
2x Hold
20%
1x Sell
10%

Analyst Opinions

10 Analysts have issued a Quidel Corporation forecast:

Buy
70%
Hold
20%
Sell
10%

Financial data from Quidel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,766 2,766
3% 3%
100%
- Direct Costs 1,665 1,665
2% 2%
60%
1,100 1,100
5% 5%
40%
- Selling and Administrative Expenses 354 354
4% 4%
13%
- Research and Development Expense 213 213
13% 13%
8%
534 534
8% 8%
19%
- Depreciation and Amortization 446 446
3% 3%
16%
EBIT (Operating Income) EBIT 88 88
28% 28%
3%
Net Profit -334 -334
81% 81%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about Quidel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quidel Corporation Stock News

Neutral
Seeking Alpha
9 days ago
Despite a once promising future, QuidelOrtho Corporation's current prospects are unappealing. I rated QuidelOrtho as a "Buy" in July 2023, but the stock has since declined by ~60% as its growth has stagnated. On 05/07/2025 the company reported top and bottom-line beats for its Q1/2025 earnings, bumping its shares up >40%.
Neutral
Seeking Alpha
13 days ago
QuidelOrtho Corporation (NASDAQ:QDEL ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Brian Blaser - President and Chief Executive Officer Joe Busky - Chief Financial Officer Conference Call Participants Conor McNamara - RBC Capital Patrick Donnelly - Citi Andrew Brackmann - William Blair Jack Meehan - Nephron R...
Neutral
Business Wire
13 days ago
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, today announced financial results for the first quarter ended March 30, 2025. “We delivered solid first quarter performance driven by growth in our Labs ...
More Quidel Corporation News

Company Profile

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Head office United States
CEO Brian Blaser
Employees 6,600
Founded 2022
Website www.quidelortho.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today